US Patent Issued to The Board of Trustees of the Leland Stanford Junior University, The United States of America, as represented by the Secretary, Department of Health and Human Services, The Regents of the University of California on Sept. 9 for "CD47 targeted therapies for the treatment of infectious disease" (American, New Zealander Inventors)

ALEXANDRIA, Va., Sept. 10 -- United States Patent no. 12,410,259, issued on Sept. 9, was assigned to The Board of Trustees of the Leland Stanford Junior University (Stanford, Calif.), The United States of America, as represented by the Secretary, Department of Health and Human Services (Bethesda, Md.) and The Regents of the University of California (Oakland, Calif.).

"CD47 targeted therapies for the treatment of infectious disease" was invented by Kipp Andrew Weiskopf (Brookline, Mass.), Kim J. Hasenkrug (Victor, Mont.), Cheryl A. Stoddart (Christchurch, New Zealand), Joseph M. McCune (San Francisco) and Irving L. Weissman (Stanford, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Methods are provided ...